These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 8353854)
1. The in vitro metabolic activation of the 11-trifluoromethyl analogue of the potent carcinogen 15,16-dihydro-11-methyl-cyclopenta[a]-phenanthren-17-one to mutagens. Boyd GW; Zepik HH; King LM; Ioannides C; Coombs MM Carcinogenesis; 1993 Aug; 14(8):1697-9. PubMed ID: 8353854 [TBL] [Abstract][Full Text] [Related]
2. Mutagenic and carcinogenic metabolites of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one. Coombs MM; Bhatt TS; Kissonerghis AM; Vose CW Cancer Res; 1980 Mar; 40(3):882-6. PubMed ID: 7471101 [TBL] [Abstract][Full Text] [Related]
3. The influence of dihydrodiol conformation on the metabolic activation of cyclopenta[a]phenanthrenes. Boyd GW; Ioannides C; Coombs MM Toxicol Lett; 1995 Jan; 75(1-3):93-100. PubMed ID: 7863542 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the metabolism and DNA binding of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one by hamster embryo cells and the human hepatoma cell line HepG2. Bhatt TS Carcinogenesis; 1986 Jan; 7(1):143-8. PubMed ID: 3002653 [TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450-dependent metabolism and mutagenicity of 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one and their implications in its carcinogenicity. Boyd GW; Young RJ; Harvey RG; Coombs MM; Ioannides C Carcinogenesis; 1993 Sep; 14(9):1783-8. PubMed ID: 8403200 [TBL] [Abstract][Full Text] [Related]
6. The mutagenicity of chemically synthesized metabolites of 16,17-dihydro-15H-cyclopenta[a]phenanthrene and its carcinogenic 11-methyl homologue. Papaparaskeva-Petrides C; Ioannides C; Boyd GW; Young RJ; Harvey RG; Coombs MM Mutagenesis; 1993 Jul; 8(4):307-10. PubMed ID: 8377648 [TBL] [Abstract][Full Text] [Related]
7. Carcinogenicity and mutagenicity of some alkoxy cyclopenta[a]phenanthren-17-ones; effect of obstructing the bay region. Bhatt TS; Hadfield ST; Coombs MM Carcinogenesis; 1982; 3(6):677-80. PubMed ID: 7116562 [TBL] [Abstract][Full Text] [Related]
8. The metabolism and activation of 15,16-dihydrocyclopenta[a]phenanthren-17-one by cytochrome P-450 proteins. Boyd GW; Young RJ; Harvey RG; Coombs MM; Ioannides C Eur J Pharmacol; 1993 Apr; 228(5-6):275-82. PubMed ID: 8482319 [TBL] [Abstract][Full Text] [Related]
9. Identification of the proximate and ultimate forms of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one. Coombs MM; Kissonerghis AM; Allen JA; Vose CW Cancer Res; 1979 Oct; 39(10):4160-5. PubMed ID: 476652 [No Abstract] [Full Text] [Related]
10. Bioactivation of the carcinogen 11-methoxy-16, 17-dihydro-15H-cyclopenta[a]phenanthrene. Catterall FS; Coombs MM; Ioannides C; Walton K Mutat Res; 2000 Feb; 465(1-2):85-90. PubMed ID: 10708973 [TBL] [Abstract][Full Text] [Related]
11. The effect of methyl substituents on the in vitro metabolism of cyclopenta[a]phenanthren-17-ones: implications for biological activity. Hadfield ST; Abbott PJ; Coombs MM; Drake AF Carcinogenesis; 1984 Nov; 5(11):1395-9. PubMed ID: 6488461 [TBL] [Abstract][Full Text] [Related]
12. Identification of trans-1,2-dihydro-1,2-dihydroxy-6-nitrochrysene as a major mutagenic metabolite of 6-nitrochrysene. El-Bayoumy K; Hecht SS Cancer Res; 1984 Aug; 44(8):3408-13. PubMed ID: 6378368 [TBL] [Abstract][Full Text] [Related]
13. The biological activity and activation of 15,16-dihydro-1,11-methanocyclopenta[a]phenanthren-17-one, a carcinogen with an obstructed bay region. Hadfield ST; Bhatt TS; Coombs MM Carcinogenesis; 1984 Nov; 5(11):1485-91. PubMed ID: 6488473 [TBL] [Abstract][Full Text] [Related]
14. The presence of a trifluoromethyl rather than a methyl substituent in the bay-region greatly decreases the DNA-binding and tumour-initiating activity of the cyclopenta[alpha]phenanthren-17-ones. Boyd GW; Coombs MM; Baird WM Carcinogenesis; 1995 Oct; 16(10):2543-7. PubMed ID: 7586164 [TBL] [Abstract][Full Text] [Related]
15. Species variation in the metabolism of 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one to its 3,4-dihydrodiol, the proximate carcinogen. Boyd GW; Coombs MM; Ioannides C; Lewis DF; Snelling J; Tsakalof A Carcinogenesis; 1995 Oct; 16(10):2351-5. PubMed ID: 7586134 [TBL] [Abstract][Full Text] [Related]
16. Mutagenicity, metabolism and DNA adduct formation of 6-nitrochrysene in Salmonella typhimurium. el-Bayoumy K; Delclos KB; Heflich RH; Walker R; Shiue GH; Hecht SS Mutagenesis; 1989 May; 4(3):235-40. PubMed ID: 2659942 [TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry of cyclopenta[alpha]phenanthrenes. Metabolites formed in vitro and in vivo from the carcinogen 15,16-dihydro-11-methyl-cyclopenta[alpha]phenanthren-17-one. Vose C; Coombs MM Biomed Mass Spectrom; 1977 Feb; 4(1):48-51. PubMed ID: 836943 [TBL] [Abstract][Full Text] [Related]
18. A comparative examination of the in vitro metabolism of five cyclopenta[a]phenanthrenes of varying carcinogenic potential. Coombs MM; Russell JC; Jones JR; Ribeiro O Carcinogenesis; 1985 Aug; 6(8):1217-22. PubMed ID: 4017190 [TBL] [Abstract][Full Text] [Related]
19. Mutagenicity of cyclopenta-fused isomers of benz(a)anthracene in bacterial and rodent cells and identification of the major rat liver microsomal metabolites. Nesnow S; Leavitt S; Easterling R; Watts R; Toney SH; Claxton L; Sangaiah R; Toney GE; Wiley J; Fraher P Cancer Res; 1984 Nov; 44(11):4993-5003. PubMed ID: 6386146 [TBL] [Abstract][Full Text] [Related]
20. Mass spectral characterisation of the major DNA--carcinogen adduct formed from the metabolically activated carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one. Wiebers JL; Abbott PJ; Coombs MM; Livingston DC Carcinogenesis; 1981; 2(7):637-43. PubMed ID: 7273343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]